Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Regulatory News (PRTC)

Share Price Information for PureTech (PRTC)

Share Price is delayed by 15 minutes
Get Live Data
124.40    -1.80 (-1.43%)
Bid:
124.00
Ask:
124.20
Spread: 0.20 (0.161%)
Market Cap: £302.81m
PRTC Live PriceLast checked at - London Stock Exchange

Intraday PureTech Share Chart

BTG

14 Aug 2019 17:30

RNS Number : 0959J
FTSE Russell
14 August 2019
 

 

 

 

 

 

Further to the FTSE Russell notice released on 12 August 2019 in relation to BTG (UK): Constituent Deletion, please note the FTSE 250 replacement.

 

All other details remain unchanged. Please see updated notice below:

 

BTG (UK): Constituent Deletion - UpdateChanges in FTSE UK Index Series

14 August 2019

Subject to court sanctioning the scheme of arrangement in relation to the cash acquisition of BTG (UK, constituent) by Bravo Bidco Ltd (non constituent), please see details of affected indexes and effective dates below:

 

 

 

BTG (UK, 0100159) will be deleted from the FTSE 250 Index.

 

Puretech Health (UK, BY2Z0H7) will be added to the FTSE 250 Index and removed from the FTSE SmallCap Index.

 

All changes effective from 19 August 2019.

 

Full details of index changes are available on the FTSE Russell website.

 

 

 

 

 

For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:

Australia

+1800 653 680

Hong Kong

+852 2164 3333

Japan

+81 3 4563 6346

London

+44 (0) 20 7866 1810

New York

+1866 551 0617

 

Alternatively please visit our website at www.ftserussell.com

Terms of Use | Copyright © 2019 FTSE Russell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FTSEZLFFKVFEBBL
Date   Source Headline
18th Aug 20257:00 amRNSNotice of Results
13th Aug 20255:12 pmRNS-RPRTC's Vedanta Announces VE202 Phase 2 Results
12th Aug 202512:00 pmRNS-RPRTC Launches Celea to Advance Ph3-Ready IPF Drug
5th Aug 20255:30 pmRNSHolding(s) in Company
1st Aug 20257:00 amRNSTotal Voting Rights
17th Jul 202512:05 pmRNS-RPRTC’s Seaport Begins Phase 2b Study in MDD
16th Jul 20257:00 amRNSPureTech Announces Leadership Transition
8th Jul 20255:45 pmRNSDirectorate Change
4th Jul 20255:30 pmRNSPDMR Notification
4th Jul 20255:30 pmRNSPDMR Notification RSU Vesting
4th Jul 20255:30 pmRNSPDMR Notification RSU Vesting
1st Jul 20257:00 amRNSTotal Voting Rights
26th Jun 20257:00 amRNS-RPRTC'S Vor Announces RemeGen License & $175M PIPE
16th Jun 20255:27 pmRNSResult of AGM
29th May 20255:30 pmRNSHolding(s) in Company
22nd May 202512:00 pmRNS-RPRTC to Present at Jefferies Healthcare Conference
21st May 20257:00 amRNS-RPRTC: IPF Data Support Lung Function Stabilization
9th May 202512:00 pmRNS-RPRTC Publishes Research on Unmet IPF Patient Needs
1st May 202512:00 pmRNS-RPRTC To Present Ph2b IPF Results at ATS Conference
30th Apr 20257:00 amRNSFinal Results
23rd Apr 20257:00 amRNSNotice of Results
11th Apr 20257:00 amRNSHolding(s) in Company
9th Apr 20253:00 pmRNSForm 8.3 PURETECH HEALTH PLC
9th Apr 20257:00 amRNS-RPRTC Appoints Peel Hunt Joint UK Corporate Broker
8th Apr 20252:53 pmGNWInvesco Ltd: Form 8.3 - PureTech Health PLC; Opening Position disclosure
8th Apr 20252:48 pmEQSForm 8.3 - The Vanguard Group, Inc.: PureTech Health plc
8th Apr 20251:15 pmRNSForm 8.3 -PURETECH HEALTH PLC
8th Apr 20251:10 pmRNSForm 8.3 PURETECH HEALTH PLC
8th Apr 202511:40 amGNWForm 8.3 - [PURETECH HEALTH PLC - Opening Disclosure - 07 04 2025] - (CGAML)
8th Apr 202510:00 amRNSForm 8.3 - Puretech Health plc
7th Apr 20255:22 pmRNSRule 2.8 Announcement
7th Apr 20254:27 pmRNSStatement re Possible Offer
11th Mar 202511:05 amRNS-RPRTC's Seaport Adds Finance/Operations Exec to BOD
3rd Mar 20257:00 amRNSTotal Voting Rights
27th Feb 20255:30 pmRNSPDMR Notification RSU Vesting
25th Feb 202512:00 pmRNS-RPRTC Presents at Leerink Partners Healthcare Conf
12th Feb 202512:05 pmRNS-RPRTC's Seaport Publishes New Glyph Platform Data
27th Jan 20257:00 amRNS-RPRTC's Vedanta Publishes Ph2 in Nature Medicine
8th Jan 202512:00 pmRNS-RPureTech to Present at the JP Morgan Conference
6th Jan 20257:00 amRNS-RPureTech Appoints UBS as UK Corporate Broker
16th Dec 20247:00 amRNSPRTC's Ph2b in IPF Successful; New SOC Potential
11th Dec 20245:30 pmRNSHolding(s) in Company
27th Nov 20245:31 pmRNSHolding(s) in Company
27th Nov 20245:30 pmRNSHolding(s) in Company
1st Nov 20247:00 amRNSTotal Voting Rights
31st Oct 20245:00 pmRNSDirector/PDMR Shareholding
21st Oct 20247:00 amRNSPRTC's Seaport Closes $225M Series B Financing
27th Sep 20247:00 amRNSKarXT/Cobenfy Approved by FDA; PRTC Receives $29M
6th Sep 20246:13 pmRNSHolding(s) in Company
28th Aug 20247:01 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.